Last Posted: Oct 31, 2019
- Pharmacogenomics as a tool to prevent drug-related hospitalization of elderly cardiology-oncology patients receiving chemotherapeutic agents and multiple symptomatic treatments: a pilot study planned for the Italian health system.
Di Francia R et al. European review for medical and pharmacological sciences 2019 Oct 23(19) 8695-8701 - The future of pharmacogenetics in the treatment of migraine.
Borro Marina et al. Pharmacogenomics 2019 Oct - Standardizing CYP2D6 Genotype to Phenotype Translation: Consensus Recommendations from the Clinical Pharmacogenetics Implementation Consortium and Dutch Pharmacogenetics Working Group.
Caudle Kelly E et al. Clinical and translational science 2019 Oct - Clopidogrel Pharmacogenetics - Why the Wait?
Roden Dan M et al. The New England journal of medicine 2019 10 (17) 1677-1678 - A Genotype-Guided Strategy for Oral P2Y 12 Inhibitors in Primary PCI.
Claassens Daniel M F et al. The New England journal of medicine 2019 Oct (17) 1621-1631 - Predictive genetic biomarkers for the efficacy of methotrexate in rheumatoid arthritis: a systematic review.
Eektimmerman Frank et al. The pharmacogenomics journal 2019 Oct - The Three Ps: Psychiatry, Pharmacy, and Pharmacogenomics, a Brief Report From New Zealand.
Maggo Simran D S et al. Frontiers in psychiatry 2019 10690 - Knowledge And Attitudes Of Pharmacy Students Towards Pharmacogenomics Among Universities In Jordan And West Bank Of Palestine.
Jarrar Yazun et al. Pharmacogenomics and personalized medicine 2019 12247-255 - Pharmacogenomics, biomarker network, and allele frequencies in colorectal cancer.
López-Cortés Andrés et al. The pharmacogenomics journal 2019 Oct - DNA Tests For Psychiatric Drugs Are Controversial But Some Insurers Are Covering Them
G Dangor, NPR, October 17, 2019
.png)
No hay comentarios:
Publicar un comentario